Herbal granule shows promise for stroke patients in early trial
NCT ID NCT07163702
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 33 times
Summary
This study tests a Chinese herbal medicine called Xinglou Chengqi Granule in 60 people who recently had an acute ischemic stroke. The goal is to find the best dose and see if it helps improve stroke symptoms and daily function. Participants will be monitored for up to 90 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dongzhimen Hospital, Beijing University of Chinese Medicine
Richmond, British Columbia, V7E 6J1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.